➤ NO SCOTUS REVIEW, from p.21
not legally related to the children.
Had the court taken this case,
its current conservative majority
could have abrogated Brooke S.B.
and similar decisions from other
states that have been important
precedents according equal standing
to same-sex parents. The denial
of review means the law will
continue to develop in the lower
courts for now without intervention
by the Supreme Court — at
least a temporary victory for LGBTQ
rights advocates.
The Supreme Court’s denial of
review in another case, Calgaro
v. St. Louis County, was expected
since even the conservative Eighth
Circuit Court of Appeals found no
merit to Anmarie Calgaro’s claim
she is entitled to damages from
institutions and individuals that
assisted her child, a transgender
girl, when she decided to leave her
unsupportive home before she had
reached age 18 in order to transition.
Calgaro argued unsuccessfully
in the federal district court in
Minnesota and before the Eighth
Circuit that her constitutional
rights as a mother were violated
when the county and its public
health director, the local school
district and high school principal,
and other private institutions
respected her child’s wishes and
kept Anmarie in the dark about
where her child was living. She
also objected to being excluded
from decisions about her child’s
transition.
The case raises important issues,
but the Supreme Court has
shown great reluctance to get
involved with cases that are effectively
moot, and in this case
E.J.K., the child in question, has
long passed the age of 18, thus
achieving adult status under Minnesota
law and being entitled to
emancipate herself from control
by her mother.
Calgaro is represented by the
Thomas More Society, a Catholic
lawyers group that generally
focuses on religious free exercise
cases, occasionally in opposition
to LGBTQ rights. E.J.K. is represented
by the National Center for
Lesbian Rights. Two conservative
groups fi led amicus briefs urging
the high court to take the case.
TOP $ PAID
FOR JUDAICA
COLLECTIBLES
HOUSE
CALLS
SAME DAY
SERVICE
AVAILABLE
SAME SERVICE
AVAILABLE
HOUSE
CALLS
SERVING
MANHATTAN
AND THE ENTIRE
TRI-STATE AREA
ANTIQUES AND ESTATE BUYERS
WE W
PAY $ CASH $ FOR
ALL GOLD, GOLD & STERLING SILVER
COSTUME JEWELRY, ALL COINS, PAPER
MONEY & STAMP COLLECTIONS
ALL GOLD...BROKEN OR NOT
PRE- 1960 FURNITURE, CLOCKS &
WATCHES (WORKING OR NOT)
TIFFANY, BACCARAT, LALIQUE
YERS
The List is Endless
Q
MILITARY
Collections Wanted
Swords, Knives,
Helmets, etc.
SEE OUR AD IN THE SUNDAY POST
516-974-6528
ASK FOR CHRISTOPHER
www.AntiqueAndEstateBuyers.com
for Antique
ANTIQUE & ESTATE BUYERS
We buy anything old. One piece or house full.
WILL TRAVEL. HOUSE CALLS. WILL TRAVEL
ENTIRE
TRI-STATE!
WILL WILL TRAVEL.TRAVEL. WE WE MAKE HOUSE HOUSE CALLS.
CALLS.
1029 WEST JERICHO 37W 47TH TURNPIKE,ST, NYC
SMITHTOWN, L.I.
New Yorkers Need Relief from Rx Greed
There’s not a lot Congress
agrees on these
days, but the need to reduce
soaring prescription
drug prices is one
imperative representatives
of both parties support.
And for good reason;
Americans pay the highest
brand name drug
prices in the world.
So when Congress returns
from its August recess,
it’s time for action.
As part of its nationwide
#StopRxGreed campaign,
AARP is advocating
to:
negotiate lower drug
prices – as the Veterans
Administration already
does, at substantial savings,
and as a recent national
poll shows voters
50 and older of all stripes
support (95% of independents,
93% of Republicans
and 90% of Democrats),
of pocket prescription
D,
-
creases to no more than
inflation.
-
sive generics to market,
by among other things
banning so-called “pay
to delay” deals in which
drug makers actually
pay generic manufacturers
to keep their cheaper
version of drugs off the
shelves – for 17 months
on average.
Big Pharma has
raised drug prices more
than inflation every year
for decades, and prescriptions
are getting
harder and harder to afford.
The average annual
cost of brand name prescription
drug treatment
grew more than five
times the average annual
New Yorker’s income between
2012 and 2017 - 58%
vs. 11.5%. And it hasn’t
let up; the average drug
price increased 10.5% in
the first six months of
2019 - five times the rate
of inflation.
Insulin is a prime example.
The cost of the drug
on which people with diabetes
rely nearly tripled
from 2002 to 2013. And it’s
not like insulin is new;
it was invented almost a
century ago. The problem:
drug companies make
small changes so they can
extend their patent protections
and manipulate the
system.
Some patients desperate
for insulin go to Canada
– where prescription
drugs are much cheaper -
while others actually risk
their lives by rationing or
skipping doses.
Your prescriptions
won’t work if you can’t afford
them.
We’re all affected by
skyrocketing drug prices,
through higher insurance
premiums and the taxes we
-
ment health care programs
for older and poor/disabled
Americans.
Older Americans are
-
care Part D enrollees take
an average of 4.5 prescriptions
per month and struggle
to pay for them on a median
annual income of just
$26,000.
A 2019 national AARP
survey of voters age 50 and
older found nearly 40%
did not fill a prescription,
mainly because of cost.
Congress needs to
stand up to the pharmaceutical
industry, which is
fighting tooth and nail to
-
cently sued the Trump administration
to keep the
list prices of their drugs
secret. The industry is
spending record amounts
on Washington lobbyists
FREE
Estimate
and running ads claiming
more affordable drugs
would actually harm consumers.
States can act too. So
far this year, 29 states have
passed 47 new laws aimed
at lowering prescription
drug costs, according to
the National Academy for
State Health Policy. New
York could – and should -
-
islature passed a bill to
prohibit out-of-pocket prescription
cost increases
on health plan enrollees
in the middle of a contract
year, and AARP is urging
Governor Andrew Cuomo
to sign the bill when it
reaches his desk.
In Washington, fighting
high drug prices has engendered
rare, bipartisan
agreement that something
should be done. New York’s
congressional delegation is
in a position to lead on this
issue and make a difference.
Now is the time.
– Chris Widelo is
AARP’s Associate State Director
for New York City
GayCityNews.com | November 7 - November 20, 2019 21
/www.AntiqueAndEstateBuyers.com
/www.AntiqueAndEstateBuyers.com
/GayCityNews.com